Anteo Diagnostics Ltd (ADO):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Anteo Diagnostics Ltd (ADO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C11407
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Anteo Diagnostics Ltd (Anteo Diagnostics) is a leading medical technology company that develops and commercializes healthcare products. The company along with its subsidiaries provides immunoassays, in-vitro diagnostics, and point of care (PoC) tests to life sciences, bio-separation, clinical diagnostic, and medical device markets, including a PoC test for the diagnosis of heart attacks (troponin test). It holds patents for nanometre-thin primers, binders, and coatings. Anteo Diagnostics’s patented nanoglue technology, Mix&Go, finds application in healthcare industry. The company is also investigating its nanoglue technology for attaching bio-molecules to synthetic surfaces and evaluating its potential in the manufacture of batteries. It has subsidiaries in Australia, Belgium and Spain. Anteo Diagnostics is headquartered in Brisbane, Queensland, Australia.

Anteo Diagnostics Ltd (ADO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Anteo Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Anteo Diagnostics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Anteo Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Anteo Diagnostics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Anteo Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Anteo Diagnostics Ltd, Medical Equipment, Deal Details 11
Private Equity 11
Bergen Global Opportunity Fund Invests USD1.5 Million in Anteo Diagnostics 11
Partnerships 12
Anteo Diagnostics Enters Into Licensing Agreement With eBioscience For Mix&Go Technology 12
Anteo Diagnostics Partners with Atomo Diagnostics 13
Anteo Diagnostics Enters Into Distribution Agreement With Gennova Scientific For Mix&Go 14
Equity Offering 15
Anteo Diagnostics Raises USD1 Million in Third Tranche of Private Placement of Shares 15
Anteo Diagnostics to Raise USD8.6 Million in Rights Offering of Shares 16
Anteo Diagnostics Completes Private Placement Of Shares For US$5 Million 17
Debt Offering 18
Anteo Diagnostics to Raise USD10.6 Million in Private Placement of 10% Notes 18
Acquisition 19
Anteo Diagnostics Sells DIAsource to BioVendor for USD19 Million 19
Anteo Diagnostics Completes Acquisition of DIAsource for USD16.7 Million 20
Anteo Diagnostics Ltd – Key Competitors 21
Anteo Diagnostics Ltd – Key Employees 22
Anteo Diagnostics Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Aug 31, 2018: Anteo Diagnostics: 30 June 2018 unaudited preliminary financial statements 24
Sep 01, 2017: Anteo Diagnostics: 30 June 2017 Preliminary Financial Statements 25
Apr 28, 2017: Anteo Diagnostics: Quarterly Activities Report 26
Corporate Communications 29
Sep 10, 2018: Anteo Diagnostics: Appointment of chief executive officer 29
Apr 09, 2018: Anteo Diagnostics: CEO Resignation and CEO Appointment 30
Apr 03, 2018: Anteo Diagnostics: Chairman Appointed and Board Changes 31
Dec 06, 2017: Anteo Diagnostics: Appointment of Chief Executive Officer 32
Sep 01, 2017: Management changes resulting from sale of DIAsource 33
Product News 34
Jan 12, 2017: Anteo Diagnostics Strengthening its Intellectual Property Position in Medical Device Arena 34
Other Significant Developments 35
Jul 30, 2018: Anteo Diagnostics: Activities report – Quarter ended 30 June 2018 35
Apr 27, 2018: Anteo Diagnostics: Activities Report – Quarter Ended 31 March 2018 38
Jan 31, 2018: Activities Report – Quarter Ended 31 December 2017 40
Oct 31, 2017: Anteo Diagnostics: Activities Report – Quarter Ended 30 September 2017 42
Jan 31, 2017: Anteo Diagnostics: Quarter Ended 31 December 2016 45
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
Anteo Diagnostics Ltd, Medical Equipment, Key Facts, 2018 2
Anteo Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Anteo Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Anteo Diagnostics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Anteo Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Anteo Diagnostics Ltd, Deals By Market, 2012 to YTD 2018 9
Anteo Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Bergen Global Opportunity Fund Invests USD1.5 Million in Anteo Diagnostics 11
Anteo Diagnostics Enters Into Licensing Agreement With eBioscience For Mix&Go Technology 12
Anteo Diagnostics Partners with Atomo Diagnostics 13
Anteo Diagnostics Enters Into Distribution Agreement With Gennova Scientific For Mix&Go 14
Anteo Diagnostics Raises USD1 Million in Third Tranche of Private Placement of Shares 15
Anteo Diagnostics to Raise USD8.6 Million in Rights Offering of Shares 16
Anteo Diagnostics Completes Private Placement Of Shares For US$5 Million 17
Anteo Diagnostics to Raise USD10.6 Million in Private Placement of 10% Notes 18
Anteo Diagnostics Sells DIAsource to BioVendor for USD19 Million 19
Anteo Diagnostics Completes Acquisition of DIAsource for USD16.7 Million 20
Anteo Diagnostics Ltd, Key Competitors 21
Anteo Diagnostics Ltd, Key Employees 22
Anteo Diagnostics Ltd, Subsidiaries 23

List of Figures
Anteo Diagnostics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Anteo Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Anteo Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Anteo Diagnostics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Anteo Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Anteo Diagnostics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Anteo Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Anteo Diagnostics Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Anteo Diagnostics Ltd (ADO):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Purepoint Uranium Group Inc (PTU):企業の財務・戦略的SWOT分析
    Purepoint Uranium Group Inc (PTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • JAND, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary JAND, Inc. (JIN), doing business a warby parker, is a manufacturing company. The company engages in operations of optical manufacturer. JIN product portfolio consists of eyeglasses, sunglasses, and gift cards. The company also manufactures and sale of eyewear for men and women. It also offer …
  • Cancer Genetics Inc (CGIX)-医療機器分野:企業M&A・提携分析
    Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that offers diagnostics products and services in oncology areas. The company offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. Its oncology tests and laboratory services offer critical genomic inform …
  • EndoGastric Solutions Inc-医療機器分野:企業M&A・提携分析
    Summary EndoGastric Solutions Inc (EGS), formerly EsophyX, Inc. is a medical equipment company that manufactures and markets gastroenterology and surgical products. The company’s products include esophy-x device and serosa-fuse fasteners. Its esophy-x device is used in reconstructing the gastroesoph …
  • ReShape Lifesciences Inc (RSLS):医療機器:M&Aディール及び事業提携情報
    Summary ReShape Lifesciences Inc (ReShape), formerly known as EnteroMedics Inc is a medical device company that develops minimally invasive medical devices to treat obesity and metabolic diseases. The company develops vBloc, a therapy used in the treatment of gastrointestinal and neurometabolic dise …
  • JCR Pharmaceuticals Co Ltd (4552):企業の財務・戦略的SWOT分析
    JCR Pharmaceuticals Co Ltd (4552) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Duskin Co Ltd:企業の戦略・SWOT・財務情報
    Duskin Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Duskin Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Neovasc Inc (NVC):企業の財務・戦略的SWOT分析
    Summary Neovasc Inc (Neovasc) is a medical device manufacturing company that manufactures, develops, and sells cardiovascular disease products. The company’s products include Neovasc reducer, Neovasc tiara, and Neovasc tissue products. Its Neovasc tiara is a novel transcatheter device that is design …
  • Recipharm AB:企業のM&A・事業提携・投資動向
    Recipharm AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Recipharm AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Tata Advanced Systems Ltd:企業の戦略・SWOT・財務情報
    Tata Advanced Systems Ltd - Strategy, SWOT and Corporate Finance Report Summary Tata Advanced Systems Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Sypris Solutions Inc (SYPR):企業の財務・戦略的SWOT分析
    Sypris Solutions Inc (SYPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Logitech International SA (LOGN):企業の財務・戦略的SWOT分析
    Logitech International SA (LOGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • TTEC Holdings Inc.:企業の戦略・SWOT・財務情報
    TTEC Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary TTEC Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • International Standard Resources Holdings Ltd (91):石油・ガス:M&Aディール及び事業提携情報
    Summary International Standard Resources Holdings Ltd (International Standard Resources), formerly New Smart Energy Group Ltd is a diversified company. The company’s business activities include coalbed methane, treasury, and electronic components. Its coalbed methane project includes CBM project, wh …
  • Windtree Therapeutics Inc (WINTD):企業の財務・戦略的SWOT分析
    Windtree Therapeutics Inc (WINTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Purdue Pharma Canada-製薬・医療分野:企業M&A・提携分析
    Summary Purdue Pharma Canada (Purdue Pharma), a subsidiary of Purdue Pharma L.P., is a research-based pharmaceutical company which focuses on development, manufacturing and commercialization of medicines for patients and healthcare professionals. The company portfolio of products includes laxatives, …
  • ENGlobal Corp (ENG):石油・ガス:M&Aディール及び事業提携情報
    Summary ENGlobal Corp (ENGlobal) is a specialty engineering services firm that offers oilfield automation solutions. The firm’s services comprise automation integration, engineering and construction, subsea controls and integration, and automation engineering and design services. Its automation inte …
  • Recylex SA:企業の戦略・SWOT・財務分析
    Recylex SA - Strategy, SWOT and Corporate Finance Report Summary Recylex SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • iCardiac Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary iCardiac Technologies Inc (iCardiac) is a provider of medical laboratory services. The company’s services portfolio include cardiac safety and respiratory services, cardiac safety assessment methodology, clinical trials, electrophysiology, drug development, regulatory services, protocol deve …
  • Curtiss-Wright Corporation (CW)-エネルギー分野:企業M&A・提携分析
    Summary Curtiss-Wright Corporation (Curtiss-Wright) is a diversified industrial company. It designs, manufactures and overhauls precision components and provides highly engineered and critical-function products, systems and services. Its offerings include sensor handling systems, surface technology …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆